Amplifying the GBM Family Voice: Real-Time Insights to Accelerate Trial Design and Enrollment

  • Sharing how the GBM AI Agent—an anonymized, real-time support platform engages thousands of glioblastoma families worldwide
  • Capturing the lived experience behind treatment choices, clinical trial interest, and barriers to participation
  • These insights act as a continuous, global focus group, offering researchers, biotech, and advocacy leaders actionable intelligence to refine trial design, strengthen recruitment, and ensure cutting-edge therapies reach the patients who need them most